الصفحة الرئيسية>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>LYN-1604 hydrochloride

LYN-1604 hydrochloride

رقم الكتالوجGC36517

هيدروكلوريد LYN-1604 هو منشط قوي يشبه UNC-51 كيناز 1 (ULK1) (EC50 = 18.94 نانومتر) للبحث عن سرطان الثدي السلبي الثلاثي (TNBC)

Products are for research use only. Not for human use. We do not sell to patients.

LYN-1604 hydrochloride التركيب الكيميائي

Cas No.: 2216753-86-3

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
183٫00
متوفر
2mg
92٫00
متوفر
5mg
135٫00
متوفر
10mg
237٫00
متوفر
25mg
491٫00
متوفر
50mg
834٫00
متوفر
100mg
1530٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description of LYN-1604 hydrochloride

LYN-1604 hydrochloride is a potent ULK1 activator with an EC50 of 18.94 nM. EC50: 18.94 nM (ULK1)[1]

LYN-1604 is found as a potential ULK1 activator with enzymatic activity of 195.7% at 100 nM and IC50 of 1.66 μM against MDA-MB-231 cells. LYN-1604 displays a good effect on ULK1 activation with an EC50 of 18.94 nM. LYS50, LEU53, and TYR89 are key to the activation site of LYN-1604. LYN-1604 induces cell death in MDA-MB-231 cells. LYN-1604 could modulate ATF3 and RAD21 through ULK1 in MDA-MB-231 cells. LYN-1604 can also increase cleavage of caspase3 and induce apoptosis. LYN-1604 induces cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis[1].

LYN-1604 could significantly inhibit the growth of xenograft MDA-MB-231 cells. The body weights of mice are stable. LYN-1604 induces remarkable autophagy in vivo. LYN-1604 has good therapeutic potential by targeting ULK1-modulated cell death of TNBC, thus making a ULK1 agonist that can be utilized as a new drug for triple negative breast cancer therapy[1].

[1]. Zhang L, et al. Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo. Chem Sci. 2017 Apr 1;8(4):2687-2701.

Protocol of LYN-1604 hydrochloride

Kinase experiment:

The ULK1 kinase enzyme, substrate, ATP and compound (include LYN-1604) are diluted in kinase buffer. Then, 1 μL of compound or (5% DMSO), 2 μL of ULK1 kinase enzyme or purified wild-type and mutant ULK1 (K50A, L53A, Y89A) (10 ng), or 2 μL of MBP (0.1 μg/μL)/ATP (10 μM) mix are added to the wells of a 384 well low volume plate. After incubation at room temperature for 60 minutes, 5 μL of kinase assay reagent is added per well. The plates are incubated at room temperature for 40 minutes and then 10 μL of kinase detection reagent is added. After incubation at room temperature for 30 minutes, the luminescence is recorded. The EC50 values are calculated using nonlinear regression with normalized dose response fitting[1].

Cell experiment:

MCE-7, MDA-MB-231 and MDA-MB-468 cells are treated with LYN-1604, cell viability is measured by the MTT assay[1].

Animal experiment:

Mice: Mice are injected subcutaneously with MDA-MB-231 cells. When the tumors reach 100 mm3 in volume, the mice are divided into four groups. Three groups are treated with different doses of LYN-1604 once a day by intragastric administration for 14 days (low dose, 25 mg/kg; median dose, 50 mg/kg; high dose, 100 mg/kg), whereas the control group is treated with vehicle control. During the treatment, the tumor volumes and body weight are measured every day until the end of the study. At the end of treatment, all mice are sacrificed. The spleen, liver, kidney and tumor tissue are harvested, weighed, and photographed, then immediately frozen in liquid nitrogen or fixed in formalin[1].

References:

[1]. Zhang L, et al. Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo. Chem Sci. 2017 Apr 1;8(4):2687-2701.

Chemical Properties of LYN-1604 hydrochloride

Cas No. 2216753-86-3 SDF
Canonical SMILES ClC1=CC=C(C(CN2CCN(C(CN(CC(C)C)CC(C)C)=O)CC2)OCC3=CC=C(C=CC=C4)C4=C3)C(Cl)=C1.[H]Cl
Formula C33H44Cl3N3O2 M.Wt 621.08
الذوبان DMSO: 100 mg/mL (161.01 mM) Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of LYN-1604 hydrochloride

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 1.6101 mL 8.0505 mL 16.101 mL
5 mM 0.322 mL 1.6101 mL 3.2202 mL
10 mM 0.161 mL 0.805 mL 1.6101 mL
  • حاسبة المولارية

  • حاسبة التخفيف

  • Molecular Weight Calculator

كتلة
=
تركيز
x
مقدار
x
ميغاواط *
 
 
 
** عند إعداد حلول المخزون، دائمًا استخدم الوزن الجزيئي الخاص بالدفعة للمنتج على ملصق القارورة MSDS / CoA (متوفر عبر الإنترنت).

احسب

In vivo Formulation Calculator (Clear solution) of LYN-1604 hydrochloride

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

مراجعات

Review for LYN-1604 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for LYN-1604 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.